Singulex

News, research & analysis about Singulex, a California-based company that is a leading provider of life science products including single molecule counting technology, biomarker research, and cardiovascular monitoring.

April 4, 2017

Singulex Announces CE Marking for Sgx Clarity® System & Expands Collaboration with European Clinical Laboratories

[vc_row][vc_column][vc_column_text] California-based Immunodiagnostics company Singulex have announced that they have received CE marking for the Sgx Clarity® system, a fully-automated IVD platform powered by the company’s […]
June 25, 2015

Merck Millipore Acquire Exclusive Rights to Singulex Single Molecule Counting Technology

Merck Millipore and Singulex, the developer and leading provider of Single Molecule Counting (SMC™) technology for clinical diagnostics and scientific discovery, have announced that they have […]
October 28, 2014

Singulex Announces Expansion of National Sales Force for Clinical Lab Business

Company terminates existing sales agreement with BlueWave Healthcare Consultants Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and […]
October 18, 2013

Singulex Secures $55 Million USD in Debt and Equity Financing

Singulex, Inc., the leading provider of Single Molecule Counting (SMC™) technology for scientific discovery and clinical testing services, today announced it has secured a debt facility […]